Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by artecdesignon Mar 13, 2014 9:39pm

140 Views

Post# 22321087

RE:RE:RE:this is the game!!!!

In on what?? You need to be in NX, they are drilling in the next few days on one property and Alpha is taking performing Radon testing on another, some thousand samples. Expect results soon. OR wait here for management to keep price down so they can take options and dream with the pumpers about how all the other properties are doing so well.

Bullboard Posts

Cannabix advances marijuana breathalyzer tech